World Investment Advisors Has $571,000 Stock Position in Axon Enterprise, Inc $AXON

World Investment Advisors boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 35.8% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 690 shares of the biotechnology company’s stock after buying an additional 182 shares during the period. World Investment Advisors’ holdings in Axon Enterprise were worth $571,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. TCTC Holdings LLC grew its stake in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 24 shares during the last quarter. Banque Transatlantique SA acquired a new position in shares of Axon Enterprise during the 1st quarter worth approximately $31,000. Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise during the 1st quarter worth approximately $32,000. Flaharty Asset Management LLC acquired a new position in shares of Axon Enterprise during the 1st quarter worth approximately $33,000. Finally, Hemington Wealth Management grew its position in shares of Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 17 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on AXON. Bank of America increased their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a research report on Tuesday, August 5th. UBS Group reiterated a “neutral” rating and set a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Finally, Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target on the stock in a research report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the transaction, the chief executive officer owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. This represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Hadi Partovi purchased 1,358 shares of the company’s stock in a transaction dated Wednesday, August 13th. The shares were acquired at an average cost of $740.00 per share, with a total value of $1,004,920.00. Following the purchase, the director directly owned 237,938 shares of the company’s stock, valued at approximately $176,074,120. The trade was a 0.57% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have sold 59,932 shares of company stock worth $45,115,616 over the last 90 days. Insiders own 4.40% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $732.23 on Monday. The company has a market cap of $57.48 billion, a price-to-earnings ratio of 180.80, a PEG ratio of 29.49 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The firm has a 50 day simple moving average of $731.05 and a 200 day simple moving average of $733.88. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm’s revenue was up 32.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.20 EPS. Research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.